Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
about
Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Kras mutation is a marker of w ...... f colorectal liver metastases.
@en
Kras mutation is a marker of w ...... f colorectal liver metastases.
@nl
type
label
Kras mutation is a marker of w ...... f colorectal liver metastases.
@en
Kras mutation is a marker of w ...... f colorectal liver metastases.
@nl
prefLabel
Kras mutation is a marker of w ...... f colorectal liver metastases.
@en
Kras mutation is a marker of w ...... f colorectal liver metastases.
@nl
P2093
P2860
P356
P1433
P1476
Kras mutation is a marker of w ...... f colorectal liver metastases.
@en
P2093
Constantinos T Sofocleous
David B Solit
Efsevia Vakiani
Elena N Petre
Karen T Brown
Mithat Gonen
Nancy E Kemeny
Stephen B Solomon
Waleed Shady
P2860
P304
66117-66127
P356
10.18632/ONCOTARGET.19806
P407
P577
2017-08-02T00:00:00Z